JMI Partner Matt Emery Named to GrowthCap’s Top Healthcare Investors of 2026
JMI Equity, a growth equity firm focused on investing in exceptional software and AI-driven companies, is pleased to announce that Partner Matt Emery has been recognized by GrowthCap as one of the Top Healthcare Investors of 2026.
GrowthCap’s annual recognition highlights investors who are not only driving strong investment performance, but who also partner closely with founders and management teams to build innovative companies that are transforming healthcare. As the industry continues to evolve rapidly across AI-enabled care, healthcare software, and tech-enabled services, this year’s honorees are helping shape how care is delivered, experienced, and managed.
Reflecting on the current landscape, Matt noted:
“We’re in the most consequential period I’ve ever seen in healthcare investing. AI is fundamentally changing what’s possible in healthcare – not just automating tasks but enabling care teams to operate at a level of effectiveness that wasn’t achievable before. The companies that earn the right to lead their categories over the next decade will be the ones that embed these capabilities into the core of how care gets delivered. Partnering with founders and management teams – and earning the right to be the most valuable partner they’ve ever had – is what drives me every day.”
Matt joined JMI in 2006 and focuses on JMI’s investments in high-potential software and AI-driven companies, including healthcare IT businesses. Matt has held numerous board positions at JMI portfolio companies during his tenure and currently oversees the investments or serves on the boards of Boulevard, CipherHealth, Clio, Jane Software, Parachute Health, PointClickCare, and TimelyCare. He played an active role with investments in Axonify (acquired by Luminate Capital Partners), Capsule Tech (acquired by Qualcomm), Healthx (acquired by Zipari), Navicure (acquired by Bain Capital), and Workfront (acquired by Adobe).
We congratulate Matt on this well-deserved recognition.
Disclaimer: This award reflects the opinion of the party conferring the award and should not be considered an endorsement of JMI Equity. Issued by GrowthCap, LLC (“GrowthCap”) in March 2026, the Top Healthcare Investors of 2026 award was based on GrowthCap’s evaluation of each nominee’s professional achievements over the course of their careers, including nomination submissions by JMI Equity. GrowthCap assessed nominees using proprietary research, nomination submissions, and feedback from colleagues, peers, and portfolio company leaders. After the results were determined, JMI Equity accepted the awards and paid per-recipient fees for publication of the award and recognition of recipients, as well as inclusion in GrowthCap’s annual publication and other related editorial and marketing materials. Receipt of such compensation presents a potential conflict of interest, and other providers or surveys may reach different conclusions.
